Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Faster, Cheaper Stem Cells: Fate Therapeutics Co-Founder, With Scripps Team, Finds Key
|
Luke Timmerman |
10/18/09 |
National
|
|
Dendreon Recruits Aces to Board, Amgen Seeks to Raise Hit Rate, Lee Hood Startup Gets $30M, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/15/09 |
Seattle
|
|
Amazon Invests in Engine Yard, PopCap Raises $22.5M, Omeros Goes Public, & More Seattle-Area Deals News
|
Gregory T. Huang |
10/14/09 |
Seattle
|
|
Lee Hood’s New Company Snags $30M to Spot Cancer and Alzheimer’s in Early Days
|
Luke Timmerman |
10/14/09 |
Seattle
|
|
Domain Raises a $500M VC Fund, Dissident Prods Amylin Again, Avanir Passes Pivotal Test, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
08/13/09 |
San Diego
|
|
Ichor Gets $3.3M Alzheimer’s Grant
|
Bruce V. Bigelow |
08/06/09 |
San Diego
|
|
Protecting America’s Leadership in Biotech Discovery
|
James N. Thomas |
08/06/09 |
Seattle
|
|
No More Tears: Avanir Investors Await Trial Results on Emotional Outburst Drug
|
Denise Gellene |
07/23/09 |
San Diego
|
|
Targeted Genetics Faces Extinction, Cell Therapeutics Unloads Debt, Dendreon Raises $221M, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
05/14/09 |
Seattle
|
|
Epix Seeks Strategic Alternatives
|
Luke Timmerman |
05/12/09 |
Boston
|
|
ProteoTech Raises $519K
|
Luke Timmerman |
05/11/09 |
Seattle
|
|
Acadia Shares Soar on Alliance With Biovail for Parkinson’s Psychosis Drug
|
Luke Timmerman |
05/04/09 |
San Diego
|
|
TargAnox Launches with $5.1M Series A Round, Targeting Oxidative Stress to Treat Diseases
|
Ryan McBride |
03/30/09 |
Boston
|
|
Epix Pharma Appoints Gamzu CEO
|
Ryan McBride |
03/05/09 |
Boston
|
|
Stopping Alzheimer’s Cold: Satori Raises $22M to Pursue Its Vision
|
Luke Timmerman |
01/08/09 |
Boston
|
|
Ceregene Drug Fails in Parkinson’s Trial
|
Luke Timmerman |
12/01/08 |
San Diego
|
|
Biotech Survival Index: Boston Life Sciences Companies Brace for Long, Hard Winter
|
Luke Timmerman |
11/25/08 |
Boston
|
|
Seattle’s Pharma Godfather, Ben Shapiro, Sees Potential Here To Transform Medicine Despite Setbacks
|
Luke Timmerman |
11/17/08 |
Seattle
|
|
Torrey Pines Therapeutics Sells Alzheimer’s Program to Partner
|
Bruce V. Bigelow |
11/10/08 |
San Diego
|
|
Fidelity Biosciences Pumps $65M into EnVivo Pharma
|
Luke Timmerman |
10/31/08 |
Boston
|
|
Sirtris’ Red Wine Chemical to Take Back Seat to “Potent” Diabetes Drugs
|
Ryan McBride |
10/23/08 |
Boston
|
|
Neuroptix Raises $18.5M For Alzheimer’s Diagnostic Test
|
Luke Timmerman |
10/22/08 |
Boston
|
|
Link Medicine Raises $40 Million to Counter Neurodegenerative Disease
|
Wade Roush |
09/30/08 |
Boston
|
|
Proteostasis Eyes Technique to Keep Your Proteins in Balance
|
Luke Timmerman |
09/15/08 |
Boston
|
|
Quanterix Developing Instrument to Detect Cancer at its Earliest, Most Curable Stages
|
Luke Timmerman |
08/29/08 |
Boston
|
|
Epix Secures $50 Million Capital Commitment
|
Luke Timmerman |
08/05/08 |
Boston
|
|
Epix CEO Resigns After Bumpy Road with Products for Depression, Alzheimer’s
|
Luke Timmerman |
07/28/08 |
Boston
|
|
Epix Unveiling Full Alzheimer’s Results at Medical Meeting, No More Surprises
|
Luke Timmerman |
07/22/08 |
Boston
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
